Share Name Share Symbol Market Type Share ISIN Share Description
Angle Plc LSE:AGL London Ordinary Share GB0034330679 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25p -0.52% 48.25p 48.00p 48.50p 48.50p 48.25p 48.50p 42,823.00 16:03:01
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 0.4 -5.4 -8.6 - 36.10

Angle Share Discussion Threads

Showing 44326 to 44349 of 44350 messages
Chat Pages: 1774  1773  1772  1771  1770  1769  1768  1767  1766  1765  1764  1763  Older
DateSubjectAuthorDiscuss
23/1/2017
17:06
miavoce, I like the fact that ii's are here, however is that a guarantee of success? It's definitely not, as they dont get it right all the time, however lets hope theyhave on this occasion. share price is pretty stable anyway.
m5
23/1/2017
11:14
I do hope that, on Thursday, we find out who the big partner is.
semper vigilans
23/1/2017
11:07
I think it's nice to see the two filtered boys having a little chat to each other over the weekend. Keeps them out of trouble elsewhere. ;-)
mikepompeyfan
23/1/2017
08:02
Fray is a complete muppet, being hanging around AGL for years. Just a bit sad really, but will be gone for good soon enough. Once those Ovarian results are out and the share price is heading north he will have nowhere to hide.
trotterstrading
23/1/2017
06:11
Fraybentos- what is your beef? If you dislike AGL so much, why post?? Why not just move on - unless you get off by attempting to irritate other holders. For sure your posts do not inform...
shaker44
22/1/2017
22:22
This is the perfect place to discuss the pros and cons of AGL. However, why do the critics keep popping up only when the shares are falling? Why do they keep copy and pasting the same points, often in capitals for effect? Personally I have no problem with a critic posting their thoughts about AGL but just because others don't see it your way, don't throw you toys out of the pram.
alloa2003
22/1/2017
22:01
I guess you class ii's who invested at 64p as mug punters fray ?
miavoce
22/1/2017
21:05
what is fair value for agl tiny revenues many competitors board of directors underperforming ctcs will not in the long term be used for cancer detection there is no proof of the value of ctcs for any other purpose no fda approval this year machine not fully automated delays in trials starting further dilution required absent deal lack of market confidence given revenues slow prospects and the above difficulties £10m perhaps on a good day so without a deal or pumped share price agl is worthless dilution required will be too high to make investable good news for mug punters the share price is higher than it should be bad news for mug punters the share price is falling
fraybentos2
22/1/2017
13:53
I rate ANGLE a BUY at this level. Im hoping for good news and theres a chance the share price will go up. My only mistake was to buy too many shares in angle. Ive reduced by over half, now hold 18,000 or so, still far far too many.
escapetohome
22/1/2017
13:35
That is your opinion. What you term speculation i term critical thinking. FOR EXAMPLE: WHAT IF COMPETITORS ARE CATCHING UP? WHAT IF SPECIFICITY IS NOT QUITE WHAT ITS CLAIMED? WHAT IF WE ARE LOSING OUR ADVANTAGE? DO WE NEED A STRONG PARTNER? WHAT MAKES FOR A STRONG SHARE PRICE! These are not speculations these are debating points, this is learning not everything is rose tinted. It is not this rubbish at all as is your claim. I have found the debate around these points interesting. I wholeheartedly reject your claim.
escapetohome
22/1/2017
13:15
but it's is all rubbish and not useful for anybody!
ali47fish
22/1/2017
09:42
Im afraid angle is a very speculative share. It is not a gsk or a lloy. Therefore : people speculate!
escapetohome
22/1/2017
09:34
thank you miacoce and trotter for injecting some sense of realism and sobriety on this board- as always so many people here are speculating d wish they stop
ali47fish
21/1/2017
22:49
Http://www.kmov.com/story/33472534/epic-sciences-to-contribute-to-cancer-moonshot-blood-profiling-atlas Epic are interesting, not least because they have some of the kind of pharma tie ups we might hope to see from AGL in the future. Very high quality BOD as well. Like a lot of US CTC co's they seem to be CLIA oriented. eg Http://investor.genomichealth.com/releasedetail.cfm?releaseid=978466 "No Cell Left Behind", sounds kind of caring.:)
banshee
21/1/2017
10:45
Investor Sentiment the way a company finances its growth ( dilution of shares) Management prowess Sales revenue are the 4 main things which influence a share price despite what magic product it may have.
escapetohome
20/1/2017
21:56
I doubt we will get any news about partner tie up in the interims Escape - this would be big news and would be announced as soon as it happens - the chances of it happening on the exact day of the interims would be very slim. I hope to see good sales growth and good progress on Ovarian and MBC trials. Hi Bookbroker, other than the share price performance, in what way has the progress over the last 12 been a monstrous disappointment ? Angle appear to be progressing to plan and we are seemingly on track to have the first FDA approved CTC capture and harvesting tool. Given the potential market size and the fact that we are ahead of the field it seems a bit nonsensical to pronounce the co dead in the water.
miavoce
20/1/2017
21:24
It cant be long now, 6 days maximum to wait for what i hope will be full update , giving more information about sales, prospects, the partner tie up. Hopefully it will enable investors to clearly see the way forward for angle and to know the future is sound and funding is in place from a large company partner with muscle and clout and influence where angle needs to drive forward.
escapetohome
20/1/2017
21:09
I think this co. Is dead in the water, Newland has been talking it up suggesting big news is on the way, but frankly this has been a monstrous disappointment, I think that Parsotix has a very limited role as a research tool and that's about it! So much hope coupled with tangible limitations!
bookbroker
20/1/2017
20:24
If Parsortix is used as a screening test in "healthy" subjects I would hope the Parsortix would pick up prostate cancer early, before there is a tumour of a sufficient size to show on MRI.
clausentum
20/1/2017
14:27
If liquid biopsy using Parsortix proves to be as effective as MRI scan in detecting prostate cancer, then there is every chance that the NHS will be trail blazers using this product, because it will be cheaper and more accessible than an MRI scanner.
chippyfriday
20/1/2017
14:17
Why don't you just ask Andrew these questions? Why bother arguing back and forth without all the facts? It's just confuses readers and creates uncertainty on the BBWe have the benefit of the most responsive CEO on the AIM, use him.
trotterstrading
20/1/2017
13:58
Semoper all the other labs I have looked at that offer CTC testing have this 96 hour restriction for what is already an FDA Approved test, so obviously the FDA don't have a problem with it. handling CTC samples is well established procedure and has been going on for over a decade, the need to treat CTC samples rapidly is well documented elsewhere. It's not an insurmounable issue re leasing extra machines, it just pushes the cost up/hassle factor somewhat, if you are a hospital administrator. There is little chance imo that the NHS will be significant trailblazers with this product anyway.
banshee
20/1/2017
13:26
That is what a blood test for ctc's would allow,BUT you have to change the dinosaur's within the medical profession ways of doing things ! In the current world the money saving aspect is greater than ever and that is what will make it win in the end. It still takes sometime to culture the solid biopsy by the way! How well Angle has done in the past few years time will tell,BUT any competitor will probably find it harder without the first mover advantage that parsortix has or had. Because they will need something significantly more effective to yet again change those dinosaurs minds ! That is the play and time will tell.....
aja5
20/1/2017
13:21
Banshee I think that AGL have had to show to the FDA that blood samples can hang around for a reasonable time at different temperatures. If the demand is high for the test, extra machines will have to be bought/leased. If it were me, I would be prepared to pay for my test and not rely on the machinations of the NHS.
semper vigilans
Chat Pages: 1774  1773  1772  1771  1770  1769  1768  1767  1766  1765  1764  1763  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20170123 19:00:15